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To the editor: Haris reported that peritoneal dialysis patients
with low turnover bone disease treated with the low-calcium
solution showed an increase of serum parathyroid hormone
(PTH) levels and improvement of bone turnover.1 However,
we experienced a 40-year-old patient on peritoneal dialysis
for chronic nephritis who showed marked change in the
volume of a parathyroid adenoma and the serum PTH level
according to changes of the calcium concentration in the
peritoneal dialysis solution. The patient was on dialysis with
2 l of peritoneal dialysis solution in four bags. After the
calcium concentration of the dialysate was reduced from 1.5
to 1.25 mM, the patient’s intact PTH (iPTH) level increased,
even though administration of activated vitamin D had
become possible. After the calcium concentration of the
dialysate was returned to 1.5 mM, the iPTH level decreased
(Figure 1). Ultrasonography of the neck revealed the
development of a parathyroid adenoma when the patient
had a high iPTH level. This adenoma disappeared after the
iPTH level decreased. Kidney/Disease Outcomes Quality
Initiative (K/DOQI) guidelines recommended the calcium
concentration of dialysate at 1.25 mM.2 However, it has
become a clinical concern that use of new drugs, such as
sevelamer hydrochloride may increase PTH levels. We
previously reported that PTH level increased significantly
after the calcium concentration of the dialysate was decreased
from 1.5 to 1.25 mM.3 Therefore, the calcium concentration
of dialysate should be determined on an individual basis
rather than uniformly.
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Yokoyama et al.1 presented a case of a 40-year-old patient
on continuous ambulatory peritoneal dialysis, whose
dialysate calcium (Ca) concentration was reduced from
1.5 to 1.25 mM. During the approximately 3 years of low Ca
treatment, the level of parathyroid hormone (PTH)
increased markedly and a parathyroid adenoma appeared.
Both the elevated level of PTH and the parathyroid
adenoma reversed after increasing the dialysate Ca
concentration back to 1.5 mM.
PTH secretion strongly depends – beside the serum
phosphate and the calcitriol concentration – on the serum-
ionized Ca level. The serum Ca concentration in a
continuous ambulatory peritoneal dialysis patient, is
determined by the ion’s absorption from the gut, from
dietary Ca intake and consumed Ca-containing phophate
binders, the net flux from bone and the net Ca loss-or-gain
from the dialysate. The latter can be positive or negative,
depending on the dialysate Ca concentration, its difference
from the patient’s ionized Ca level and the amount of
ultrafiltration.2 Hypocalcemic episodes can stimulate PTH
secretion, and even provoke adenoma formation in the
parathyroid gland. According to the findings of Duncan
et al.3 and Buijsen et al.4 the higher the baseline PTH, the
l e t t e r t o t h e e d i t o r http://www.kidney-international.org
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Clinical course in the patients
 iPTH
Figure 1 | Clinical course of the patients. After the calcium
concentration of the dialysate was reduced from 1.5 to 1.25 mM, the
patient’s iPTH level increased from 180 to 990 pg/ml, even though
administration of activated vitamin D had become possible. After the
calcium concentration of the dialysate was returned to 1.5 mM, the
iPTH level decreased to 31 pg/ml.
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